617 filings
Page 17 of 31
CORRESP
9np4g1yezto
6 Jun 17
Correspondence with SEC
12:00am
CORRESP
y40oik
5 Jun 17
Correspondence with SEC
12:00am
8-K
d5hfdxcshc52yrlcng
5 Jun 17
VBI Vaccines to Present at Jefferies 2017 Global Healthcare Conference
12:00am
CORRESP
inmoeswbwcdob
2 Jun 17
Correspondence with SEC
12:00am
UPLOAD
jqmwvyhbganz
30 May 17
Letter from SEC
12:00am
S-3
ls77rkyd
15 May 17
Shelf registration
12:00am
10-K/A
pzluq5rbcoz00zp19zl
15 May 17
Annual report (amended)
12:00am
10-Q
ctsoowz9ej0ebeed
15 May 17
Quarterly report
12:00am
DEFA14A
zlp8j6tu
11 May 17
Additional proxy soliciting materials
12:00am
DEF 14A
ggzv3wz3ct2a
11 May 17
Definitive proxy
12:00am
8-K
qq62fcnv
2 May 17
VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study
12:00am
PRE 14A
irjlr
1 May 17
Preliminary proxy
12:00am
8-K
n8v0aj4 0d2soyez
20 Apr 17
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
3h4042rc3 0fc
11 Apr 17
Regulation FD Disclosure
12:00am
8-K
bcegwtczdu60m0pvzi
5 Apr 17
Regulation FD Disclosure
12:00am
8-K
u52zfrn 5qfgks
30 Mar 17
Entry into a Material Definitive Agreement
12:00am
10-K
w66q0f3l 7cw2h9fym3
20 Mar 17
Annual report
12:00am
8-K
y18i5vw2 6skkbfqar6
22 Feb 17
VBI Vaccines Receives Positive Response from Health Canada’s Initial Evaluation of the Proposed Sci-B-Vac Phase III Clinical Program
12:00am
8-K
0nf 9vzxal07
7 Feb 17
Regulation FD Disclosure
12:00am
D
ghjgbz1kz0pdde
20 Dec 16
$10.6M in equity, sold $10.6M, 2 investors
12:00am